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mere descriptions ofthe X-ray findings. It allows the reader to see what something like
a "coin lesion" or "honeycomb lung" looks like on a chest X-ray.
The next two chapters discuss the causes and clinical features of the respiratory
diseases and related problems. Following each discussion is a list of up-to-date
recommendations on how each problem should be investigated and managed.
Although therapy is briefly discussed in the previous chapters, it is presented
separately and more completely as the final chapter of the book. In addition to the
discussion of all the current therapeutic modalities, side effects of therapy and drug
interactions are also discussed.
This clinical manual has many strengths: it is concise and very well written, with 13
tables and 157 illustrations, a pleasant surprise in such a small book; it has a detailed
index for easy referencing; and, finally, its light weight makes it easy to carry on the
wards.
A few points should be noted, however. First, the epidemiology of the diseases is
discussed mainly with data from the United Kingdom. Second, the author does not
cross-reference the topics to the major textbooks. Last, a list of abbreviations and a
glossary of the uncommon syndromes would have been appropriate additions to the
book.
Nevertheless, I recommend this book as the number one choice for a quick review of
respiratory medicine. It is a worthwhile, handy reference manual.
HEDAYATOLLAH ZAGHI
MedicalStudent
Yale University School ofMedicine
THE HISTORY OF SCURVY AND VITAMIN C. By Kenneth J. Carpenter. New York,
Cambridge University Press, 1986. 288 pp. $39.95.
If our libraries were left to the majority of scientific authors, they would surely
become storehouses for countless treatises on the most insipid ofsubjects, all written in
a similar prosaic, unimaginative style. For this reason, a book such as The History of
Scurvy and Vitamin Cis gladly welcomed as a well-written and interesting account of
the history of mankind's battle with scurvy and of the isolation and production of
vitamin C.
Thematically, the volume may be divided into two sections. The first seven chapters
deal with various outbreaks ofscurvy through the ages. The author begins with Vasco
da Gama's voyage around the Cape of Good Hope in 1498 and continues to the
outbreaks ofinfantile scurvy in the early part ofthis century. Also included are several
interesting chapters on land scurvy during the Great Potato Famine of 1845-48 and
during the British expeditions to the Arctic in the latter halfofthe nineteenth and the
early twentieth centuries. Skillfully woven into each chapter is a thorough discussion of
the prevailing views of scurvy at each period, as well as an analysis of the various
theories and hypotheses concerning the elusive etiology ofthis disease.
Above all else, the author should be commended for his ability to set each chapter
firmly in its appropriate historical framework. The last three chapters deal with the
isolation of Vitamin C, the elucidation of its chemical structure, and the first use of
animal models to test various hypotheses about the causes ofscurvy.
The book demonstrates that man's understanding of scurvy was often confused and
that the etiology of this disease remained the subject of numerous diverse hypotheses.60 BOOK REVIEWS
In addition, the role of vitamin C/citrus fruit as an effective antiscorbutic agent was
challenged time and again.
Perhaps the only criticism of this study is that the reader may come away from the
first seven chapters unable to summarize man's understanding ofscurvy at the start of
the twentieth century. Otherwise, any reader with even the slightest interest in scurvy
or vitamin C will probably have a difficult time putting the volume down.
ELAN D. Louis
MedicalStudent
Yale University School ofMedicine
MOBILIZING AGAINST AIDS: THE UNFINISHED STORY OF A VIRUS. Institute of
Medicine, National Academy ofSciences. Cambridge, MA, Harvard University Press,
1986. 212 pp. $7.95. Paperbound.
Knowledge about acquired immune deficiency syndrome (AIDS) is increasing
rapidly, as is the disease itself. When, therefore, should an authoritative body such as
the Institute of Medicine (IOM) release a document summarizing what is known
about the disease? It is certain to be out of date soon. The following may be a
reasonable set ofcriteria: first, enough is known about the disease to give a reasonable
summary, second, there is an urgent need for an authoritative presentation to quiet
public fears, and third, the best available data and thinking are needed to guide public
policy. On all three counts, the timing ofthis volume is appropriate.
For those not familiar with the Institute of Medicine, it is a unit of the National
Academy of Sciences (NAS) whose purpose is "to be an adviser to the federal
government and [have] its own initiative in identifying issues ofmedical care, research,
and education." The NAS itself "was established in 1863 by Act of Congress as a
private, nonprofit, self-governing membership corporation for the furtherance of
science and technology, required to advise the federal government upon request within
its fields ofcompetence." Clearly, then, this book is quasi-official, in that it represents
advice to the federal government as a function of the IOM/NAS charter. It is also an
independent scientific, rather than an official government, document.
Ifthe above dicta make it a kind ofhybrid effort, the authorship makes it even more
so. Eve K. Nichols, a professional science writer, took the presentations from the
annual meeting ofthe IOM on October 16, 1985, added discussions with distinguished
experts on AIDS and subsequent literature (up to April 1986), and combined these
into a volume that is readable enough for the non-clinician and yet authoritative
enough to serve as a handbook for persons working in the field.
Twoofthe most valuable assets for those without medical training are a glossary and
a list oforganizations to contact for more information on AIDS (Appendix E). For the
person concerned with the details of policy in public or private settings, there are
Appendices B ("Public Health Service [PHS] Recommendations for Preventing
Transmission of Infection with HTLV-III/LAV in the Workplace"), C ("Additional
PHS Recommendations to Reduce Sexual and Drug Abuse-Related Transmission of
HTLV-III/LAV"), and D ("PHS Recommendation: Education and Foster Care of
Children Infected with HTLV-III/LAV"). For the clinician and epidemiologist there
are Appendix A ("Current Centers for Disease Control [CDC] Definition ofAIDS"),
a list ofthe microorganisms known to cause opportunistic infections in AIDS patients,
and a list of the antiviral drugs currently being tested for use in AIDS therapy. For